CN Patent
CN105658652B — 可用于治疗与kit相关的病症的组合物
Assigned to Cable Chart Pharmaceutical Co · Expires 2019-04-12 · 7y expired
What this patent protects
本文描述可用于治疗与突变KIT相关的病症的化合物和组合物。
USPTO Abstract
本文描述可用于治疗与突变KIT相关的病症的化合物和组合物。
Drugs covered by this patent
- Ayvakit (AVAPRITINIB) · Blueprint Medicines
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.